JB Pharma Q2 Results: Net profit jumps 16% to Rs 175 crore, revenue up 13%
business.
The company posted Rs 151 crore in the same quarter last year.
The company’s revenue from operations rose to Rs 1,001 crore in Q2 FY25, a 13 per cent Y-o-Y rise from Rs 882 crore reported in Q2FY24.
JB Pharma’s domestic business grew by 22% YoY to Rs 588 crore, driven by strong demand for products such as Cilacar, Cilacar-T, Rantac, Nicardia, Metrogyl, and Sporlac.
Operating EBITDA grew by 13% to Rs 285 crores, while EBITDA margins remained constant at 28.4%.
Stock Trading
Stock Markets Made Easy
By — elearnmarkets, Financial Education by StockEdge
Stock Trading
Markets 102: Mastering Sentiment Indicators for Swing and Positional Trading
By — Rohit Srivastava, Founder- Indiacharts.com
Stock Trading
Commodity Markets Made Easy: Commodity Trading Course
By — elearnmarkets, Financial Education by StockEdge
Stock Trading
Point & Figure Chart Mastery: A Comprehensive Trading Guide
By — Mukta Dhamankar, Full Time Trader, 15 Years Experience, Instructor
Stock Trading
Options Trading Made Easy: Options Trading Course
By — Anirudh Saraf, Founder- Saraf A & Associates, Chartered Accountant
Stock Trading
Ichimoku Trading Unlocked: Expert Analysis and Strategy
By — Dinesh Nagpal, Full Time Trader, Ichimoku & Trading Psychology Expert
Stock Trading
Market 101: An Insight into Trendlines and Momentum
By — Rohit Srivastava, Founder- Indiacharts.com
Stock Trading
Macroeconomics Made Easy: Online Certification Course
By — Anirudh Saraf, Founder- Saraf A & Associates, Chartered Accountant
Stock Trading
Options Trading Course For
